ConductScience.org, home

Paper23282970

Exclusion of histiocytes/endothelial cells and using endothelial cells as internal reference are crucial for interpretation of MGMT immunohistochemistry in glioblastoma.

Hsu CY and 8 others. Am J Surg Pathol, 2013. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Exclusion of histiocytes/endothelial cells and using endothelial cells as internal reference are crucial for interpretation of MGMT immunohistochemistry in glioblastoma. Papers, record 23282970. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23282970

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exclusion of histiocytes/endothelial cells and using endothelial cells as internal reference are crucial for interpretation of MGMT immunohistochemistry in glioblastoma.
PubMed
Journal
Am J Surg Pathol
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.57
iCite
Revised in PubMed
2026-01-28
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hsu CYChih-Yi
2Lin SCShih-Chieh
3Ho HLHsiang-Ling
4Chang-Chien YCYi-Chun
5Hsu SPSanford P-C
6Yen YSYu-Shu
7Chen MHMing-Hsiung
8Guo WYWan-You
9Ho DMDonald M-T

Source PubMed

Download CSV of authors

Topics29

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
DNA Modification MethylasesMajor topic
DNA Repair EnzymesMajor topic
Endothelium, VascularMajor topic
GlioblastomaMajor topic
HistiocytesMajor topic
Tumor Suppressor ProteinsMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Alkylating
Biomarkers, Tumor
Child
Child, Preschool
DNA Methylation
Dacarbazine
Female
Humans
Male
Middle Aged
Predictive Value of Tests
Promoter Regions, Genetic
Staining and Labeling
Survival Rate
Taiwan
Temozolomide
Treatment Outcome
Young Adult

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
33710615Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.Cochrane Database Syst Rev2021https://conductscience.org/library/papers/33710615PubMed
32320427The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapy.PLoS One2020https://conductscience.org/library/papers/32320427PubMed
30673883Predictive markers for MGMT promoter methylation in glioblastomas.Neurosurg Rev2019https://conductscience.org/library/papers/30673883PubMed
30500933MGMT: Immunohistochemical Detection in High-Grade Astrocytomas.J Neuropathol Exp Neurol2019https://conductscience.org/library/papers/30500933PubMed
30310321An intronic genetic variation of MGMT affects enhancer activity and is associated with glioma susceptibility.Cancer Manag Res2018https://conductscience.org/library/papers/30310321PubMed
29036186The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.PLoS One2017https://conductscience.org/library/papers/29036186PubMed
28693158Relationship between MGMT gene expression and treatment effectiveness and prognosis in glioma.Oncol Lett2017https://conductscience.org/library/papers/28693158PubMed
26769142Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma.Mod Pathol2016https://conductscience.org/library/papers/26769142PubMed
26538496Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer.Target Oncol2016https://conductscience.org/library/papers/26538496PubMed
25575938Prognosis of glioblastoma with faint MGMT methylation-specific PCR product.J Neurooncol2015https://conductscience.org/library/papers/25575938PubMed
25391970MGMT promoter methylation in non-neoplastic brain.J Neurooncol2015https://conductscience.org/library/papers/25391970PubMed
25286040Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls.CNS Oncol2014https://conductscience.org/library/papers/25286040PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MGMT4255PubTator's text mininghttps://conductscience.org/library/genes/4255

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23282970

GET https://conductscience.org/api/papers/v1/23282970/authors